[Succès de traitement par Cabergoline d'une série de cas de cardiomyopathie du péripartum, incluant un cas critique nécessitant une assistance circulatoire mécanique]

Ann Cardiol Angeiol (Paris). 2023 Oct;72(4):101610. doi: 10.1016/j.ancard.2023.101610. Epub 2023 Jun 8.
[Article in French]

Abstract

Peripartum cardiomyopathy is a life-threatening condition that requires urgent diagnosis and management. Bromocriptine was established as disease specific therapy; less data is known about Cabergolin which is another prolactin secretion inhibitor. In this paper we report 4 peripartum cardiomyopathy cases treated successfully with Cabergoline, including a cardiogenic shock case requiring mechanical circulatory support.

Keywords: Cabergoline; Cardiogenic shock; Cardiomyopathie du péripartum; Mechanical circulatory support; PPCM; VA ECMO; assistance circulatoire mécanique; chock cardiogénique.

Publication types

  • English Abstract

MeSH terms

  • Cabergoline / therapeutic use
  • Cardiomyopathies*
  • Humans
  • Peripartum Period*
  • Shock, Cardiogenic / therapy

Substances

  • Cabergoline